S

Surgical Science Sweden AB
STO:SUS

Watchlist Manager
Surgical Science Sweden AB
STO:SUS
Watchlist
Price: 129.4 SEK 0.7%
Market Cap: 6.6B SEK
Have any thoughts about
Surgical Science Sweden AB?
Write Note

Surgical Science Sweden AB
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Surgical Science Sweden AB
Total Equity Peer Comparison

Comparables:
EKTA B
CEVI
GETI B
ARJO B
S
STIL

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
S
Surgical Science Sweden AB
STO:SUS
Total Equity
kr4.6B
CAGR 3-Years
82%
CAGR 5-Years
129%
CAGR 10-Years
N/A
Elekta AB (publ)
STO:EKTA B
Total Equity
kr10.8B
CAGR 3-Years
10%
CAGR 5-Years
7%
CAGR 10-Years
N/A
CellaVision AB
STO:CEVI
Total Equity
kr739.3m
CAGR 3-Years
16%
CAGR 5-Years
19%
CAGR 10-Years
19%
Getinge AB
STO:GETI B
Total Equity
kr30.2B
CAGR 3-Years
13%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Total Equity
kr7.6B
CAGR 3-Years
10%
CAGR 5-Years
7%
CAGR 10-Years
N/A
S
Stille AB
STO:STIL
Total Equity
kr659.6m
CAGR 3-Years
82%
CAGR 5-Years
49%
CAGR 10-Years
32%

See Also

What is Surgical Science Sweden AB's Total Equity?
Total Equity
4.6B SEK

Based on the financial report for Jun 30, 2024, Surgical Science Sweden AB's Total Equity amounts to 4.6B SEK.

What is Surgical Science Sweden AB's Total Equity growth rate?
Total Equity CAGR 5Y
129%

Over the last year, the Total Equity growth was 3%. The average annual Total Equity growth rates for Surgical Science Sweden AB have been 82% over the past three years , 129% over the past five years .

Back to Top